Nectar Lifesciences Limited (NSE:NECLIFE)
18.35
+0.42 (2.34%)
Jul 16, 2025, 2:30 PM IST
Nectar Lifesciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -1,137 | 49.95 | -241.83 | 250.47 | -732.64 | Upgrade
|
Depreciation & Amortization | 623.89 | 607.18 | 591.19 | 569.68 | 602.53 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.14 | - | -404.08 | -94.07 | 1.31 | Upgrade
|
Loss (Gain) From Sale of Investments | -0.35 | -1.8 | -1.05 | -0.03 | -0.4 | Upgrade
|
Provision & Write-off of Bad Debts | 16.08 | 9.33 | 2.23 | 9.65 | -54.75 | Upgrade
|
Other Operating Activities | 271.91 | 893.53 | 610.79 | 859.77 | 803.16 | Upgrade
|
Change in Other Net Operating Assets | 1,920 | 688.67 | 779.26 | -645.42 | -405.42 | Upgrade
|
Operating Cash Flow | 1,694 | 2,247 | 1,337 | 950.05 | 213.79 | Upgrade
|
Operating Cash Flow Growth | -24.59% | 68.11% | 40.68% | 344.38% | -92.50% | Upgrade
|
Capital Expenditures | -437.95 | -294.15 | -300.6 | -249.7 | -312.41 | Upgrade
|
Sale of Property, Plant & Equipment | 0.08 | - | 797.88 | 397.31 | 1.85 | Upgrade
|
Investment in Securities | - | - | 2.5 | - | -2.5 | Upgrade
|
Other Investing Activities | 18.56 | 123.9 | 17.26 | 18.83 | 26.82 | Upgrade
|
Investing Cash Flow | -419.3 | -170.25 | 517.04 | 166.44 | -286.24 | Upgrade
|
Short-Term Debt Issued | 279.97 | - | - | - | 922.92 | Upgrade
|
Long-Term Debt Issued | - | 4.12 | 0.01 | 1,568 | 330.82 | Upgrade
|
Total Debt Issued | 279.97 | 4.12 | 0.01 | 1,568 | 1,254 | Upgrade
|
Short-Term Debt Repaid | - | -466.94 | -438.58 | -2,063 | - | Upgrade
|
Long-Term Debt Repaid | -815.11 | -720.11 | -652.39 | -10.28 | -7.28 | Upgrade
|
Total Debt Repaid | -815.11 | -1,187 | -1,091 | -2,073 | -7.28 | Upgrade
|
Net Debt Issued (Repaid) | -535.14 | -1,183 | -1,091 | -505.69 | 1,246 | Upgrade
|
Common Dividends Paid | - | - | - | - | -11.21 | Upgrade
|
Other Financing Activities | -745.78 | -871.42 | -764.87 | -688.11 | -1,120 | Upgrade
|
Financing Cash Flow | -1,281 | -2,054 | -1,856 | -1,194 | 114.9 | Upgrade
|
Net Cash Flow | -5.84 | 22.26 | -2.28 | -77.31 | 42.45 | Upgrade
|
Free Cash Flow | 1,256 | 1,953 | 1,036 | 700.35 | -98.62 | Upgrade
|
Free Cash Flow Growth | -35.66% | 88.50% | 47.91% | - | - | Upgrade
|
Free Cash Flow Margin | 7.52% | 11.59% | 6.80% | 4.20% | -0.64% | Upgrade
|
Free Cash Flow Per Share | 5.60 | 8.71 | 4.62 | 3.12 | -0.44 | Upgrade
|
Cash Interest Paid | 745.78 | 871.42 | 794.87 | 788.1 | 1,120 | Upgrade
|
Cash Income Tax Paid | - | - | - | - | 37.13 | Upgrade
|
Levered Free Cash Flow | -157.93 | 970.9 | 259.57 | -492.06 | 2,091 | Upgrade
|
Unlevered Free Cash Flow | 308.19 | 1,531 | 777.06 | -54.91 | 2,627 | Upgrade
|
Change in Net Working Capital | -677.53 | -637.76 | -518.79 | 1,010 | -2,025 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.